News

PTC Therapeutics, Inc. and Odylia Therapeutics announced a strategic collaboration to develop novel gene therapies in rare inherited retinal diseases (IRDs) utilizing the Anc80 vector…
Read More...

Boehringer Ingelheim and Yuhan Corporation announced a collaboration and license agreement for the development of a first-in-class dual agonist for the treatment of NASH and related…
Read More...

Pfizer Inc. announced the successful completion of its acquisition of the privately held clinical-stage biotechnology company Therachon Holding AG. Under the terms of the transaction,…
Read More...

PeptiDream Inc., a public Kanagawa-based biopharmaceutical company announced a new Peptide Drug Conjugate “PDC” collaboration agreement with Swiss-based Novartis. Under the agreement,…
Read More...

Aucta Pharmaceuticals announced that the Company has entered into an agreement with Eton Pharmaceuticals, Inc. to License U.S. marketing rights for AUC025. AUC025 is an innovative…
Read More...

ContraVir Pharmaceuticals, a biopharmaceutical company focused on the development of therapeutic drugs for the treatment of liver disease arising from non-alcoholic steatohepatitis…
Read More...

Velabs Therapeutics GmbH, a leader in rapid screening of functional therapeutic antibodies, announced the closing of a €3 million Series B financing round to advance its functional…
Read More...

SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products, today announced to launch Bivalirudin…
Read More...

Sartorius Stedim Biotech (SSB) launched a new vessel for its ambr 250 modular benchtop automated mini bioreactor system. The single-use vessel has been specially designed for…
Read More...

Liquidia Technologies announced that it has amended its collaboration agreement with GlaxoSmithKline (GSK) for the development and commercialization of pharmaceuticals based upon the…
Read More...

Mölnlycke and Zuellig Pharma have announced a new partnership that will focus on providing more advanced wound care products and solutions to patients and healthcare practitioners…
Read More...

Regeneron Pharmaceuticals, Inc. and Sanofi announced that the U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) for use with other medicines to treat chronic…
Read More...

Oxford BioTherapeutics Ltd. announced that it has received a milestone payment from Boehringer Ingelheim (BI). In addition to OBT’s two clinical stage assets, MEN1309/OBT076 and…
Read More...

Akorn, Inc. announced that it received a warning letter from the U.S. Food and Drug Administration (FDA) related to the inspection of its Somerset, New Jersey manufacturing facility in…
Read More...

Imbrium Therapeutics L.P., a clinical-stage biopharmaceutical company and operating subsidiary of Purdue Pharma L.P., announced it is advancing its novel, potentially first-in-class…
Read More...

C4X Discovery Holdings plc, a pioneering drug discovery company, entered into a collaboration with PhoreMost, a UK-based biopharmaceutical company dedicated to drugging ‘undruggable’…
Read More...

Intensity Therapeutics, Inc., a clinical-stage biotechnology company pioneering a novel, immune-based approach to treat solid tumor cancers through direct injection of its proprietary…
Read More...

Taiwan Liposome Company, a clinical-stage specialty pharmaceutical company dedicated to the development and commercialization of novel nanomedicines designed to target areas of unmet…
Read More...

Rafael Pharmaceuticals announced that it has entered into an out-licensing agreement with Ono Pharmaceutical Co., Ltd. (“Ono”), a pharmaceutical company committed to creating innovative…
Read More...

AbbVie Inc. and Allergan plc announced that the companies have entered into a definitive transaction agreement under which AbbVie will acquire Allergan in a cash and stock transaction…
Read More...